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1. Introduction 
The relationship between noradrenergic function, stress, and memory has long been a 
subject of interest. What is normally adaptive during situations of extreme physical threat, 
including increases in heart rate and blood pressure, increased vigilance, hyperarousal, 
exaggerated startle, and enhancement of memory storage are considered to be part of a 
response elicited in a stressful situation [1]. Indeed, emotionally arousing experiences tend 
to be well remembered, and studies over the past five decades have provided considerable 
evidence suggesting that hormones released by stressful emotional experiences play an 
important role in mediating the effects of emotional arousal on lasting memory. One of the 
brain regions involved in the stress response is the amygdala, and neuromodulatory 
influences occurring selectively within this structure have been widely shown to regulate 
memory consolidation of newly acquired information through its projections to other brain 
structures. This review will focus on evidence from research findings investigating the 
relationship between stress-elicited noradrenergic brain activation and the role of the 
amygdala in mediating the effects of norepinephrine (NE) on memory consolidation. 
Furthermore, our findings suggest that this noradrenergic activation of the amygdala or, 
more precisely, of the basolateral nucleus of the amygdala, serves to modulate memory 
storage in other brain regions. 
2. Adrenergic catecholamines and stress 
The locus coeruleus (LC) noradrenergic system plays an important role in the fear response 
and anxiety. Other brain systems are also involved in the fear response and anxiety; these 
 The Amygdala – A Discrete Multitasking Manager 204 
include the corticotrophin-releasing factor hypothalamic-pituitary-adrenal axis system and 
the benzodiazepine, dopamine, opiate, and serotonergic systems. These neuropeptide and 
neurotransmitter systems function in a coordinated manner with NE, as reviewed elsewhere 
[2-4]. 
Diverse adaptive behavioral responses are evoked by acute exposure to a variety of stressful 
events. In coordination with neuroendocrine and autonomic responses induced by such 
events, behavioral adaptations serve to maintain homeostasis and, by enabling optimal 
functioning, ensure survival in the face of threat. In addition to the primary neural circuits 
mediating contextually specific responses, acute stress also activates other brain systems 
that play a modulatory role, serving to bring together the complex response of the organism 
to any stress. Of the systems modulated by stress, the brain noradrenergic system has been 
shown to be one of the most important.  
The noradrenergic system originates in a relatively small number of cells located in the LC 
and in other cell groups in the medulla and pons that utilize NE as a neurotransmitter. 
Nonetheless, the extensive network of noradrenergic terminals projecting from these few 
cells innervates essentially the entire neural axis. This widespread and divergent anatomical 
organization allows this system to influence the activity of the entire nervous system under 
conditions of elevated noradrenergic release during stress. 
Activation of the noradrenergic system alters the ‘‘signal to noise ratio’’ of responses evoked 
by other afferents (both excitatory and inhibitory), rather than inducing simple inhibition or 
excitation, thus enhancing synaptic transmission in target circuits [5]. Such modulatory 
effects of NE have been described in many brain circuits and have been shown to be 
mediated, via different transduction mechanisms, by both β and α-adrenergic receptors [6-
9]. Given the anatomical organization of the central noradrenergic system, it is suggested 
that stimuli that activate the small population of hindbrain noradrenergic neurons result in 
the release of NE in many widespread target regions throughout the brain, altering the 
reactivity of many neural circuits mediating a variety of behavioral and physiological 
responses. Furthermore, the anatomical organization and potential modulatory effects of the 
NE system suggest that it may facilitate a number of responses evoked by other afferents. As 
a consequence, the observed effects of increased noradrenergic release in a particular 
structure will depend on the set of specific neural circuits recruited and the set of specific 
behavioral responses elicited by the stressful stimulus which provoked the increase in NE 
release. 
Noradrenergic neurons are activated by specific sensory stimuli of several modalities [10, 
11], suggesting that information from the external, as well as the internal, environment is 
transduced by a variety of sensory systems before gaining access to the noradrenergic 
system. Moreover, some data suggest that the strength of a stimulus in a particular context 
is an important factor in determining the noradrenergic response [11-13]. Both 
electrophysiological and neurochemical studies (i.e., in vivo microdialysis) have shown that 
the brain noradrenergic system is phasically and robustly activated by a diverse array of 
acutely stressful stimuli [14-21].  
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3. Adrenergic catecholamines and memory storage 
Strong memories are often based on experiences that were emotionally arousing [22]. There 
is a large body of evidence suggesting that stress hormones released by emotional 
experiences play an important role in mediating the effects of emotional arousal on lasting 
memory. There is now extensive evidence supporting the hypothesis that the strength of 
long-term memories is influenced by hormonal systems activated by experience [23, 24], i.e., 
memory formation may involve stress-released hormones as endogenous modulators of the 
neurobiological processes underlying memory consolidation.  
Gold and van Buskirk [25] were the first to suggest the involvement of central NE in 
memory. Their study showed that inhibitory avoidance (IA) training increases brain NE 
levels under conditions that result in good retention, suggesting an enhanced release of this 
neuromodulator during training. In support of this view, Haycock et al. [26] showed that 
intraventricular infusion of NE facilitates retention, providing further evidence for the view 
that central NE function modulates memory. Other studies, e.g., those of Jensen et al. [27], 
reported that intracerebroventricular administration of diethyldithiocarbamate (DDC), a 
drug that decreases central catecholamine levels, impairs IA retention when administered 
post-training. Furthermore, concurrent infusion of NE into the ventricles or systemic 
injection of NE or epinephrine blocks the retention impairment produced by peripheral 
administration of DDC [28-30]. 
Further evidence suggesting that peripherally released catecholamines may influence 
memory consolidation came from experiments using amphetamines. Amphetamine is 
known to influence the release of catecholamines from peripheral storage sites [31]. 
Numerous studies [e.g. 32-34] have shown that amphetamine enhances memory when 
administered systemically either shortly before, or shortly after training. Enhancing effects 
of amphetamine have been observed in a variety of tasks, such as IA, active avoidance, 
discriminated avoidance, and appetitive discrimination [34-36]. Moreover, the fact that 
amphetamine enhances memory when administered post-training supports the view that it 
enhances retention by influencing memory storage processes. Since amphetamine crosses 
the blood-brain barrier, other studies have examined whether its memory-modulating 
effects involve influences on peripheral or central catecholamines. Post-training systemic 
injection of 4-OH amphetamine (an amphetamine derivative that does not cross the blood-
brain barrier) was also found to enhance IA retention, whereas central injection of 
amphetamine was ineffective. The effects of systemic injection of amphetamine and 4-OH 
amphetamine do not seem to involve peripheral sympathetic neurons, the primary source of 
peripheral NE, as sympathetic denervation induced by 6-hydroxydopamine hydrobromide 
induced 24 hours before training does not attenuate the memory-enhancing effects of either 
drug. In contrast, adrenal demedullation, i.e., elimination of peripheral epinephrine, blocks 
the effects of both amphetamine and 4-OH amphetamine on memory for active avoidance 
and IA training [37].  
More recently, Williams et al. [38] showed that the memory-enhancing effects of systemic 
injection of 4-OH amphetamine are blocked by the peripherally acting β-adrenoceptor 
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antagonist sotalol. These findings provide strong support for the view that amphetamine 
influences memory storage, at least in part, through effects involving the release of 
peripheral epinephrine from the adrenal medulla. 
Systemic administration of epinephrine also enhances retention in different tasks, including 
IA [39], multitrial avoidance [40], a one-trial appetitive task [41], and an aversively 
motivated discrimination task [42]. Epinephrine is effective when given immediately after 
training; moderate doses produce the greatest enhancement, larger doses being less effective 
or even impairing retention, and the doses of epinephrine found to enhance retention 
produce plasma epinephrine levels comparable to those found after IA training [43]. 
Retention enhancement induced by epinephrine is blocked by injection of the β-
adrenoceptor antagonist propranolol, a drug that readily enters the brain [41] as well as by 
sotalol, a β-adrenoceptor antagonist that does not enter the brain [44]. Post-training 
administration of β-adrenoceptor agonists that enter the brain, including dipivefrin and 
clenbuterol, also enhances memory consolidation, and the memory enhancement induced 
by dipivefrin and clenbuterol is blocked by propranolol, but not by sotalol [44]. Moreover, 
the memory-enhancing effect of clenbuterol is selectively blocked by centrally, but not 
peripherally, acting β-adrenoceptor antagonists [45]. Although the use of systemic 
nonspecific antiadrenergic agents has clearly implicated NE in learning and memory, the 
results obtained by Introini-Collison and Baratti [45] indicate that the effects of epinephrine 
on memory storage are initiated by activation of peripheral β-adrenoceptors, but also 
involve activation of β-adrenoceptors in the brain. 
4. Route of stress-induced brain activation: from the LC to higher brain 
structures  
As epinephrine does not readily cross the blood–brain barrier [46], its effects on memory 
consolidation appear to be initiated, at least in part, by activation of β-adrenoceptors in the 
periphery. This conclusion is supported by the finding that sotalol, a β-adrenoceptor 
antagonist that does not readily enter the brain, blocks the enhancing effects of peripherally 
administered epinephrine on memory [44].  
A large number of studies have suggested that the effects of epinephrine on memory are 
most likely mediated by activation of β-adrenoceptors located on vagal afferents. For 
example, anatomical data have provided evidence that the dorsal and ventral branches of 
the vagus nerve innervate the adrenal gland [47]. In another study, Niijima [48] showed that 
electrical stimulation of the adrenal nerve evokes action potentials in the vagus nerve. More 
recently, Miyashita and Williams [49], using electrophysiological recordings of vagus nerve 
activity, showed that systemically administered epinephrine produces a significant increase 
in vagal nerve firing that is blocked by concurrent administration of  the β-adrenoceptor 
antagonist sotalol. These data clearly show that the effects of epinephrine on the brain are 
mediated, at least in part, by the activation of ascending fibers of the vagus nerve and that 
these effects of epinephrine on vagal neural discharge are mediated through influences on 
peripheral β-adrenergic receptors. 
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Information regarding somatosensory activity, including that induced by footshock, is 
transmitted by ascending vagal fibers to the nucleus of the solitary tract (NTS), a brainstem 
structure with a high population of noradrenergic neurons [50-52]. In response to vagal 
nerve activation, NTS neurons influence central noradrenergic activity through direct 
synapses on neurons in the LC. Vagal afferents send noradrenergic projections directly and 
indirectly via the LC to forebrain regions [53-55], including the amygdala [56, 57]. Moreover, 
the finding that intra-NTS infusion of the β-adrenoceptor antagonist propranolol [58] or 
inactivation of the NTS with lidocaine [59] prevents epinephrine enhancement of memory 
provides evidence that the NTS is part of a brain stem system that, together with the LC, 
enables epinephrine-induced memory enhancement. Taken together, these data suggest that 
central noradrenergic neurons arising in the NTS mediate the effects of peripheral 
physiological influences on memory consolidation. This implication is supported by 
evidence that post-training infusion of the local anesthetic lidocaine into the NTS impairs IA 
retention [59]. Moreover, injection of lidocaine into the NTS blocks the memory-enhancing 
effects of systemic post-training injection of epinephrine [55]. Thus, the NTS appears to be 
an interface between peripheral adrenergic activation and brain processes regulating 
memory consolidation.  
5. The noradrenergic system of the amygdala is involved in modulating 
memory storage  
The amygdala is principally responsible for fear and anxiety responses to threatening 
environmental stimuli, including the increase in activity of the sympathetic nervous system 
in response to threat [60-62]. The LC densely innervates the amygdala [63, 64] and, in 
particular, projects to the central and basal nuclei [65-68].  
Activation of the LC by electrical stimulation or administration of drugs (e.g. yohimbine) 
results in increased anxiety [69-72], probably as a result of the potentiation of this excitatory 
pathway from the LC to the amygdala. In addition to a role in anxiety, the LC projection to 
the amygdala may also play a role in forming and retrieving emotional memories [73, 74]. 
Interestingly, level of arousal, which is highly correlated with LC activity, determines the 
likelihood of a memory being encoded and subsequently retrieved.  
Moreover, microdialysis data have shown that acute stressful immobilization induces 
increased NE release in the stria terminalis [15, 78], an important amygdala NE afferent, and 
in the medial and central nuclei of the amygdala [75-77]. 
Although the first evidence suggesting the involvement of the amygdala in learning and 
memory was published over 65 years ago [79], it is only in recent years that the amygdala 
has become a central focus of inquiry in studies of learning and memory. There is now 
extensive evidence suggesting that it is involved in the effects of attentional and reward 
processes [80-82] and that it may be a locus of the neural changes underlying the acquired 
association of cues with emotional responses, especially the somatosensitive responses 
elicited by fearful stimuli [83-85]. In addition, there is a strong consensus that it is involved 
in mediating the effects of emotional arousal on memory.  
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Extensive evidence indicates that the effects of peripheral epinephrine on memory are 
mediated by influences involving noradrenergic activation of the amygdala. For example, 
post-training intra-amygdala infusion of the β-adrenoceptor antagonist propranolol blocks 
the memory-enhancing effects of systemically administered epinephrine [86, 87] and the 
retention deficits induced by post-training infusion of propranolol into the amygdala are 
attenuated by concurrent infusion of NE [88]. Additionally, post-training infusion of NE or 
the β-adrenoceptor agonist clenbuterol into the amygdala induces a dose-dependent 
enhancement of retention [89-91] and attenuates retention deficits induced by adrenal 
demedullation [87]. Together, these findings strongly suggest that the amygdala mediates 
the effects of epinephrine on memory storage and that the effects involve activation of β-
adrenergic mechanisms. 
 
Figure 1. Effect of low- and high-intensity footshock on NE release in the amygdala assessed by in vivo 
microdialysis and HPLC. The data are shown as the mean (±SEM) NE levels expressed as a percentage 
of basal levels before footshock. **, p < 0.01 as compared to the no footshock group [94].  
Studies using in vivo microdialysis and high performance liquid chromatography support 
these findings. The figure 1 illustrates one of the results we obtained in an experiment where 
a significant increase in NE levels was measured in the dialysis sample collected after 
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exposure to footshocks of variable intensities. Other findings in our laboratory have shown 
that training conditions that evoke emotional arousal (e.g. footshock stimulation) or direct 
injection of epinephrine or corticosterone in doses that facilitate memory significantly 
increases NE release in the amygdala and this effect is directly related to the stimulus 
intensity [92-96].  
Interestingly, it has been shown that the relative severity of the stressor and its physiologic 
impact can vary between individuals [93]. Thus, the severity of stress produced by a 
stimulus, whether physiologic or psychogenic, has typically been defined in terms of the 
magnitude of the physiological response it elicits, e.g., by measuring activation of the 
hormonal hypothalamic–pituitary–adrenal (HPA) stress axis or of the peripheral 
sympathoadrenal autonomic response system. Whereas the brief bursts of electrical activity 
elicited by distinct, innocuous stimuli occur over a period of 100’s of milliseconds, phasic 
activation of noradrenergic neurotransmission by acutely stressful stimuli is much longer 
lasting, of the order of seconds to minutes or hours, depending on the stimulus, often 
outlasting the duration of the stimulus itself, and correlates temporally with peripheral 
physiological indicators of the stress response [77, 97]. 
For example, McIntyre et al. [98] examined NE release induced by IA training and, as 
expected on the basis of our previous studies of the effects of footshock stimulation [92, 94], 
found that NE levels were increased following training. However, in their study, perhaps 
somewhat surprisingly, the duration of the increased NE levels was greater than that 
previously found with footshock stimulation given without IA training [92, 94, 99]. Their 
findings suggest that the combination of footshock and the novel contextual information 
provided by training may have increased amygdala noradrenergic activation. Additionally, 
they showed that the extent of the increase in amygdala NE levels after training predicted 
the 24-h retention performance, as animals with a larger increase in NE release after training 
had longer retention latencies than those with smaller increases. These findings, taken 
together with those of studies of drug effects on NE levels, provide strong support for the 
hypothesis that NE release in the amygdala may play a critical role in modulating memory 
consolidation [100]. 
Studies using in vivo electrophysiological recordings in the cat also demonstrated that 
delivery of a footshock during IA training significantly increases the firing rate of 
lateral/basolateral amygdala neurons for 2 h following training [101]. These findings fit well 
with evidence that memory-modulating drugs can be effective when infused into the 
amygdala within hours after training [102]. Furthermore, NE release in the amygdala is 
potentiated by peripheral injection of epinehrine, the opiate antagonist naloxone, or 
amphetamine [94, 96, 103], findings consistent with evidence that intra-amygdala infusion of 
β-adrenoceptor antagonists blocks the effect of naloxone on memory storage [104, 105]  and 
that opiate agonists inhibit the release of NE in other brain regions [106]. Moreover, the 
finding that inactivation of the NTS blocks the effects of systemic epinephrine injection on 
NE release in the amygdala supports the view that the noradrenergic fibers terminating in 
the amygdala may originate from soma in the NTS [95]. 
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6. Different adrenoceptors in the basolateral amygdala are involved in 
memory storage modulation  
Noradrenergic receptors on cells receiving an afferent input from the LC can be classified as 
α1-, α2-, or β-adrenoceptors. Activation of α1-adrenoceptors by NE generally leads to 
excitation of the follower cells [107] and there is some evidence that β-adrenoceptors are also 
excitatory [108]. In contrast, activation of α2-adrenoceptors leads to inhibition of the follower 
cells [107], and also of the noradrenergic neurones themselves (“autoreceptors”). The 
consequences of autoreceptor activation can be detected as changes in the firing rate of 
amygdala neurons and in the release of NE. Alpha2-adrenoceptors are widely distributed in 
the brain [109, 110] and there are regional differences in their role in modulating NE release 
[111]. 
Several findings indicate that the memory-modulating effects of NE and other 
neuromodulatory and neurotransmitter systems are selectively mediated by the basolateral 
nucleus of the amygdala (BLA). The first series of experiments demonstrating a selective 
involvement of the BLA in memory storage showed that lesions of the BLA, but not of the 
central nucleus of the amygdala, block the memory impairment induced by systemic 
injection of benzodiazepines [112]. Furthermore, benzodiazepines infused into the BLA 
impair retention [113], whereas infusion of a benzodiazepine antagonist into the BLA 
enhances memory [114]. The findings of subsequent experiments suggested a selective 
involvement of the BLA in mediating noradrenergic influences on memory for many kinds 
of tasks [115, 116]. For example, Hatfield and McGaugh [117] showed that post-training 
infusion of NE into the BLA enhances memory for spatial learning in a water maze. In other 
studies, we found that infusion of the β-adrenoceptor agonist clenbuterol into the BLA 
enhances IA retention [119], whereas intra-BLA infusion of propranolol impairs memory of 
the same task [117]. 
Further studies demonstrated that NE in the BLA also interacts with glucocorticoids. 
Quirarte et al. (1997) showed that systemic injection of dexamethasone enhances IA 
retention when administered after training with a relative low footshock intensity and that 
infusion of a β1 or β2-adrenergic antagonist into the BLA, but not into the central nucleus of 
the amygdala, blocks the memory-enhancing effects of systemically administration of 
glucocorticoids (Fig. 2a). They also showed that the glucocorticoid receptor agonist RU 
28362 dose-dependently increases IA retention performance when infused into the BLA and 
that this effect is blocked by post-training co-infusion of the β1-adrenoceptor antagonist 
atenolol into the BLA (Fig. 2b). These findings strongly suggest that β-adrenergic 
mechanisms in the BLA mediate the effects of epinephrine on memory storage and that β-
adrenergic receptor activation in the BLA is required in order for glucocorticoids to 
modulate memory storage processes [118] (Fig. 2a and b). 
Other findings indicate that α-adrenoceptors within the BLA are involved in the regulation 
of memory processes via an interaction with β-adrenergic mechanisms. Both α1- and α2-
adrenoceptor subtypes are expressed at high levels in the amygdala [120, 121], though α1-
adrenoceptors predominate [122-127]. Thus, the tendency to impair IA retention that we  
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Figure 2. a. Inhibitory avoidance retention latencies of animals that received pretraining infusion of the 
nonspecific β-adrenergic antagonist propranolol (0.5 μg), the β1-adrenergic antagonist atenolol (0.5 μg), 
or the β2-adrenergic antagonist zinterol (0.5 μg) into the BLA or the central nucleus of the amygdala, 
followed by immediate post-training subcutaneous injection of dexamethasone (0.3 mg/Kg). The 
columns and bars show the mean (± SEM) latency in seconds. *, p < 0.05, **, p < 0.01 compared to the 
corresponding vehicle group; ●●, p < 0.01 compared to the vehicle-dexamethasone group (n=8-
14/group) [118].  
b. Inhibitory avoidance retention latencies of animals that received concurrent administration of the 
glucocorticoid receptor agonist RU 28362 (1.0, 3.0, or 10 ng) and the β1-adrenergic antagonist atenolol 
(0.5 μg) into the BLA. The columns and bars represent the mean (± SEM) latency in seconds. **, p < 0.01 
compared to the vehicle group; ●, p < 0.05; ●●, p < 0.01 compared to the corresponding RU 28362 group 
(n = 9-13 per group) [118]. 
obtained in our series of experiments with post-training intra-BLA infusion of low doses of 
the nonselective α-adrenoceptor agonist phenylephrine [128] very likely resulted from a 
combined activation of α1- and α2-adrenoceptors. In order to clarify the role of each 
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component of the α-adrenergic system in the BLA, we tested the effect of selective activation 
and/or blockade of these receptors in the BLA during IA training. Our results showed that 
post-training α1-adrenoceptor inactivation using the selective antagonist prazosin impaired 
IA retention and that selective activation of α1-adrenoceptors by infusion of a fixed 
concentration of the α2-adrenoceptor antagonist yohimbine together with increasing 
concentrations of phenylephrine dose-dependently enhanced IA retention i.e., yohimbine 
reversed the tendency of phenylephrine to impair retention. Given the higher affinity of NE 
for α2-adrenoceptors [151] and the fact that α2-adrenoceptors are mostly located 
presynaptically [142], our results suggest that the IA memory impairing effects produced by 
phenylephrine alone are mainly due to presynaptic α2-adrenoceptor activation [152]. This 
hypothesis is consistent with evidence that activation of presynaptic α2-adrenoceptors 
blocks NE release [129 130]. 
The α1-adrenergic influence on memory seems to be mediated by an interaction with β-
adrenoceptors within the BLA. Indeed, intra-BLA post-training infusion of atenolol blocks 
the memory enhancement induced by selective activation of α1-adrenoreceptors [128]. 
Moreover, we showed that intra-BLA infusion of the α1-adrenoceptor antagonist prazosin 
right-shifts the dose-response effects of the β-adrenoceptor agonist clenbuterol when the 
two drugs are infused together into the BLA post-training [131]. These results suggest that 
α1-adrenergic activity in the BLA facilitates the effects of β-adrenergic activation on memory 
formation. In a subsequent experiment, intra-BLA infusion of the synthetic cyclic adenosine 
monophosphate (cAMP) analog 8-bromo-cAMP was found to enhance retention in a 
manner similar to clenbuterol, but the effect induced by 8-bromo-cAMP was not affected by 
prazosin [131]. These findings are consistent with pharmacological evidence suggesting that 
β-adrenoceptors modulate memory storage by a direct coupling between Gs protein and 
adenylate cyclase and that α1-adrenoceptors may act indirectly on this process by 
influencing the β-adrenergic-induced synthesis of cAMP [132-134]. 
As mentioned above, the amygdala contains α2-adrenoceptors [125-127], which might be 
located on particular subsets of neurones involved in the autonomic response to stressful 
stimuli. In order to investigate the role of these receptors in memory for IA, we performed a 
series of experiments aimed at evaluating the effect of activation or blockade of these 
receptors in the BLA on IA retention processes. The behavioral data obtained in these 
experiments showed that bilateral microinfusion of the selective 2-adrenoceptor antagonist 
idazoxan into the BLA immediately after training induces dose-dependent enhancement of 
retention performance of IA when tested 24 h later (Figure 3), whereas post-training intra-
BLA infusion of the selective 2-adrenoceptor agonist UK 14,304 induces dose-dependent 
impairment of retention performance (Figure 4). 
These results are consistent with those of studies in which systemic injection of selective α2-
adrenergic drugs was found to disrupt and enhance consolidation of IA learning in the rat 
[136]. In addition, they fit with previous reports suggesting that the effects of peripheral 
administration of α2-adrenergic compounds on learning and memory performance are 
mediated through a direct action on central NE release [136-139] and with previous results 
implicating amygdala α2-adrenoceptors in footshock-based learning [140, 141]. Moreover, 
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they clearly indicate that, in addition to involvement of α1- and β-adrenoceptors, α2-
adrenoceptors in the BLA are involved in mediating the effects of training-induced or 
experimentally administered NE on memory storage [128, 131]. As pre-synaptic α2-negative 
feedback is known to regulate NE release [142], including NE release in the amygdala [127, 
129, 130, 140], the present findings provide additional evidence that memory consolidation 
is regulated by noradrenergic activation within the BLA. 
 
Figure 3. Effect of pre- or post-training infusion of various doses of idazoxan (a selective α2-
adrenoceptor antagonist) into the basolateral amygdala on inhibitory avoidance retention latencies. The 
columns and bars represent the mean ± SEM latency (in seconds) in entering the dark compartment 
during the retention test. The pre-training groups were infused 20 min before training, whereas the 
post-training groups were infused immediately after footshock administration. *, p < 0.05 compared to 
the corresponding value in the other group; ***, P < 0.001 compared to the vehicle-injected group; ●, p < 
0.05; ●●, p < 0.01; ●●●, p < 0.001 compared to the value using 0.3 μg of idazoxan in the same group. n = 
9–13 per group [135]. 
It is difficult to speculate when, and for how long, a single infusion of an adrenergic drug 
induces its effect on NE release, since the minimal time interval between sample collection 
using the microdialysis technique is about 15 min. However, the maximal effect of α2-
adrenergic drugs on NE release has been observed 30 min after infusion [143, 144]. Since the 
effect of α2-adrenergic drugs on NE release in the brain and the effect of a footshock on NE 
release are both maximal after 30 min [98], it is likely that the effects of pre-training local 
injection of UK 14,304 or idazoxan into the BLA mainly results from binding to α2-
adrenergic autoreceptors, which regulate the stress-induced release of NE. The fact that 
retention latencies were only influenced by the highest dose of UK 14,304 [135 and Fig. 4] 
suggests that the pool of NE release induced by footshock within seconds or minutes after 
shock administration is sufficient to enable the conditioned stimulus (CS)-unconditioned 
stimulus (US) association. Our finding, shown in Fig. 4, that pre-training intra-BLA infusion 
of UK 14,304 or idazoxan induces effects on memory that are similar, but of a smaller 
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amplitude, to those obtained in post-training groups suggests that, during IA, the α2-
adrenoceptor system in the BLA is more probably involved in very fine memory-modulated 
tuning control of IA consolidation, rather than in the encoding of CS-US association, as 
suggested previously [141]. The post-training effects are clearly consistent with the 
hypothesis that IA consolidation depends critically on the training-induced prolonged 
release of amygdala NE. 
 
Figure 4. Effect of immediate post-training infusion of various doses of UK 14,304 (a selective α2-
adrenoceptor agonist) into the basolateral amygdala on inhibitory avoidance retention latencies. The 
columns and bars bars represent the mean ± SEM latency (in seconds) in entering the dark compartment 
during the retention test. The pre-training groups were infused 20 min before training, whereas the 
post-training groups were infused immediately after footshock administration. **, p < 0.01 compared to 
the corresponding value in the other group; ***, p < 0.001 compared to the vehicle-injected group; ●●●, p 
< 0.001 compared to the groups injected with 0.1 or 1.0 ng of UK 14,304; ♦♦, p < 0.01 compared to the 
groups injected with 1.0 or 3.0 ng of UK 14,304; n = 9–12 per group. [135] 
In order to test this hypothesis, we investigated the effects of systemic and intra-BLA 
blockade or activation of α2-adrenoceptors on the dynamics of NE in the BLA.  
In the first study, anesthetized animals were microdialysed in the BLA while receiving 
systemic infusions of the α2-adrenoceptor antagonist dexefaroxan or the α2-adrenoceptor 
agonist UK 14,304. Results obtained in this study showed that dexefaroxan and UK 14,304 
induced respectively a rapid and reversible significant increase and decrease, in NE levels in 
the BLA (Figure 5). 
In a second study using retrodialysis, anesthetized animals received local infusion of 
dexefaroxan or UK 14,304 and the results showed that dexefaroxan induced a significant 
and reversible increase in NE levels in the BLA, whereas UK 14,304 caused a significant 
reduction (Figure 6).  
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Figure 5. Effect of systemic 2-adrenoreceptor blockade with the antagonist dexefaroxan (0.63 mg/kg) 
or activation with the agonist UK 14,304 (0.63 mg/kg) on NE levels in the basolateral amygdala in 
anesthetized animals assessed by in vivo microdialysis and HPLC. Norepinephrine levels are expressed 
as a mean (±SEM) value expressed as a percentage of basal levels; n = 7–9 per group. ∗, p < 0.05; ∗∗, p < 
0.01 compared to baseline levels [145]. 
Our retrodialysis data indicate that drugs infused into the BLA post-training cause maximal 
NE release about 15 min after infusion. Moreover, this time interval has been described to be 
critical for the involvement of the amygdala during consolidation of IA [146, 147]. It is 
therefore likely that the enhancing and inhibitory effects caused, respectively, by post-
training injection of idazoxan or UK 14,304 on IA retention were due to modulation of the 
prolonged training-induced increase in NE levels [98]. Additionally, and importantly, our 
findings are consistent with those of Pelletier et al. [101] showing that a single footshock 
increases the firing of neurons in the basolateral amygdala and that the increase peaks after 
30 min, but remains high for 2 h. 
In summary, our findings show that α2-adenoreceptor-induced modulation of NE release 
during post-trial consolidation significantly influences IA retention performance. Providing 
additional evidence of the memory-modulating role of NE release in the BLA, they also 
suggest that α2-adrenoceptors in the BLA are a critical component in the modulating 
influence of NE on IA memory consolidation and that the effect is probably due to a 
prolongation of the increase in training-induced levels of NE within the BLA. However, and 
in reference to previous results showing that NE activates three types of adrenoceptors, each 
involved in a different signaling pathway, a better understanding of the mechanisms by 
which NE in the BLA modulates the process of IA retention memory requires a detailed 
characterization of the signaling pathways downstream of NE binding. Indeed, NE activates 
β-, α1-, and α2-adrenoceptors, all of which are known to be metabotropic receptors.  
Beta-adrenoreceptors are associated with activation of the protein Gs, which activates 
adenylate cyclase, leading to production of cAMP, which then activates cAMP response 
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Figure 6. Effect of local 2-adrenoreceptor blockade with the antagonist dexefaroxan or activation with 
the agonist UK 14,304 on norepinephrine levels in the basolateral amygdala in anesthetized animals 
assessed by in vivo retrodialysis and HPLC. Norepinephrine levels are expressed as the mean (±SEM) 
value expressed as a percentage of basal levels. n = 7-8 per group; ∗, p < 0.05 compared to baseline levels 
[145]. 
element-binding (CREB) protein. Alpha1-adrenoceptors can mobilize calcium ions from 
intracellular stores, as well as increase calcium entry via voltage-gated calcium channels. 
Their stimulation leads to hydrolysis of membrane phospholipids via the G protein-
mediated activation (Gq protein) of phospholipase Cβ and the resultant production of 
inositol triphosphate (IP3) induces α1-adrenoceptor-elicited calcium release from 
intracellular stores, thereby increasing the cytosolic calcium concentration. The 
simultaneously produced diacylglycerol (DAG) activates protein kinase C (PKC) [148], 
which phosphorylates many cellular substrates, including membrane channels, pumps, and 
ion-exchange proteins. Alpha1-adrenoceptors have also been reported to modulate other 
signaling pathways, resulting in increased accumulation of cAMP and cGMP, potentiation 
of cAMP responses elicited by the Gs-linked receptors, activation of phospholipase A2 and 
phospholipase D, activation of cAMP phosphodiesterase, adenosine release, and stimulation 
of arachidonic acid release [149]. Alpha2-adrenoceptors are classically linked to Gi/o protein, 
with an action opposite to that of Gs, and act by inhibiting adenylate cyclase via a Gi protein 
and thereby inhibit cAMP production, while the βγ subunits of Gi protein increase 
potassium ion conductance. Alpha2-adrenoceptors also suppress voltage-activated calcium 
channels via Go protein, thus reducing the flow of extracellular calcium ions into target cells. 
Moreover, there is increasing evidence suggesting that α2-adrenoceptors are linked not only 
to the activation of the Gi/o cascade, but also, for example, to the activation of 
phospholipase C (PLC) and PKC, at least in some cell types [150]. 
Although pharmacological data show that α2-receptors have a higher affinity than α1-
receptors for NE and that both α2- and α1-receptors have a higher affinity for NE than β-
receptors [151], little is known about the distribution of the three receptors subtypes within 
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the BLA and further research is clearly needed to determine the signaling cascades initiated 
by the binding of NE to each of these subtypes linked to the various G proteins, which 
mediate the activation of specific signal transduction pathways.  
A comparison of the differences and similarities between the three adrenoceptors in terms of 
specificity, signaling, and trafficking [152] would result in a better understanding of the 
dynamics of NE action on the intracellular cascade of event in the BLA leading to plastic 
changes underlying memory modulation of IA.  
7. Conclusions 
These studies indicate that adrenal stress hormones and the amygdala, especially the BLA, 
are involved in regulating memory consolidation. Because of its anatomical position, the 
amygdala is able to translate sympathetic arousal into synaptic plasticity that is distributed 
throughout the brain. Thus, the amygdala appears to be the core of the system involved in 
the physiological mechanisms promoting brain plasticity and rapid consolidation of 
memory for major events that drive and condition the survival of the animal. In our review, 
we suggest that the sympathetic response to a particular emotional or stressful event is 
driven along the peripheral nervous system by activating the β-adrenoceptor system on 
vagal afferents, which bridge the peripheral and central nervous systems by stimulating the 
NTS in the brainstem. As a result, adrenergic stimulation of vagal afferents that project to 
the NTS, induces activation of the NE system in forebrain structures either directly or 
indirectly via the LC onto which the NTS projects. It is therefore likely that activation of the 
vagal nerve will induce NE release in the amygdala through these two pathways.  
The evidence that memory for various kinds of tasks is not lost when the amygdala is 
inactivated or lesioned [146,147,153,154] indicates that it is not the final storage site for 
emotionally arousing memories, but modulates memory storage in efferent brain regions 
[155, 156]. Indeed, several subsequent findings suggested that amygdala stimulation 
modulates memory consolidation and does so through influences mediated by amygdala 
efferents, and it has been shown that lesion of the stria terminalis, which carries both 
afferent and efferent projections of the amygdala, blocks the impairing effects of post-
training electrical stimulation of the amygdala on memory [157]. In addition, stria terminalis 
lesions block the memory enhancement induced by post-training systemic injection of 
clenbuterol or  intra-amygdala infusion of NE [89, 91]. These results strongly suggest that 
modulatory influences on memory involve projections from the amygdala to other brain 
regions. Consistent with this view, the amygdala shares extensive connections with cortical 
and subcortical regions implicated in memory storage processes [158-160]. Concerning this 
point, a large body of data shows that memory consolidation results from the direct 
interaction of the amygdala with many brain regions, including the nucleus accumbens [161, 
162], insular cortex [163], entorhinal cortex [164, 165], rostral anterior cingulate cortex [166], 
and medial prefrontal cortex [167], and most extensively the hippocampus [168]. With 
regard to the dynamic interactions between the amygdala and limbic and temporal lobe 
structures in human and non-human animals, it has been suggested that emotional arousal-
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induced NE release in the amygdala will induce modulation of synapses in the target areas 
that are engaged in memory processing. Despite the growing literature on the memory-
modulating role of the interaction between the amygdala and other brain regions, one must 
bear in mind that the present theoretical operating system is very simplistic, since memory 
is also modulated by the interaction between many neuromodulatory systems in the BLA. 
The roles of these latter interactions in memory modulation have been extensively 
documented and considered in recent reviews [155, 168, 169]. Very briefly, findings have 
shown that opioid peptides and gamma amino butyric acid both regulate NE release in the 
amygdala. Moreover, the acetylcholine and glutamate systems play a role in memory 
modulation at steps beyond the activation of β-adrenoceptors. The effects of glucocorticoids 
on memory consolidation are indirectly mediated by activation of the NTS and LC, both 
representing afferent NE projections to the amygdala, and directly by potentiating the 
noradrenergic signal cascade within the amygdala.  
In summary, the epinephrine and NE systems, which rise, respectively from the vagus nerve 
and the NTS, to the amygdala, form a complicated network of critical mechanisms leading 
to the emergence of a memory-modulation process. Although this cannot be a complete 
representation, our data show that the memory-modulated role of NE is mediated 
differently by the various adrenergic receptors in the BLA, each of which is involved in a 
specific process. Eventually, through the activation of all of these systems, interacting inside 
and outside the amygdala, the strength of our emotional memories is determined by the 
weight of their emotional significance.  
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